Dr Keyur Bhatt

What Is Bile Duct Cancer (Cholangiocarcinoma)? Symptoms, Causes, Diagnosis and Treatment

Bile duct cancer, medically known as Cholangiocarcinoma, is a relatively rare but serious cancer that develops in the bile ducts. These ducts are responsible for carrying bile from the liver and gallbladder to the small intestine, where it helps in the digestion and absorption of fats.

Bile duct cancer can develop anywhere along the biliary system, including inside the liver, near the liver hilum or in the lower part of the bile duct near the pancreas. Since early-stage disease often produces few or nonspecific symptoms, diagnosis may sometimes occur at an advanced stage.

However, advances in diagnostic imaging, hepatobiliary surgery, minimally invasive surgery, chemotherapy and targeted therapies have improved treatment options for patients with cholangiocarcinoma.

Understanding the warning signs and seeking timely medical attention are important steps towards early diagnosis and appropriate treatment.

What Is Cholangiocarcinoma?

Cholangiocarcinoma is a cancer that originates from the cells lining the bile ducts. These ducts form a network of small tubes that transport bile produced by the liver towards the small intestine.

Bile plays an essential role in digestion, particularly in breaking down dietary fats.

When cancer develops in the bile ducts, it can cause narrowing or blockage of the normal bile flow. This may result in jaundice, itching, dark-coloured urine and other digestive or abdominal symptoms.

Cholangiocarcinoma is different from gallbladder cancer and liver cancer, although these conditions involve closely related organs and structures.

What Are the Different Types of Bile Duct Cancer?

Depending on where the cancer develops, cholangiocarcinoma is classified into three major types.

1. Intrahepatic Cholangiocarcinoma

This cancer develops in the small bile ducts located within the liver.

It may present as a mass inside the liver and is sometimes detected incidentally during an ultrasound, CT scan or MRI performed for another reason.

Common features include:

  • Abdominal discomfort or pain, particularly in the right upper abdomen.

  • Unexplained weight loss.

  • Loss of appetite.

  • General weakness and fatigue.

  • Occasionally, jaundice.

Treatment often involves surgical removal of the affected portion of the liver, depending on the tumour's size, location and extent.

2. Perihilar Cholangiocarcinoma (Klatskin Tumour)

This cancer develops at the junction where the right and left hepatic bile ducts join, near the liver hilum.

It is also known as a Klatskin tumour.

This is a technically challenging type of bile duct cancer because of its proximity to major blood vessels and important structures entering and leaving the liver.

Patients commonly develop:

  • Yellowing of the eyes and skin (jaundice).

  • Dark-coloured urine.

  • Pale or clay-coloured stools.

  • Severe itching.

  • Loss of appetite and weight loss.

Surgery may require removal of the bile duct along with part of the liver and regional lymph nodes. Complex biliary reconstruction is often necessary.

3. Distal Cholangiocarcinoma

This cancer develops in the lower portion of the common bile duct, near where it passes through or behind the pancreas before opening into the small intestine.

It commonly causes obstruction of bile flow, resulting in jaundice.

Other symptoms may include:

  • Abdominal pain.

  • Unexplained weight loss.

  • Itching.

  • Dark urine.

  • Pale stools.

Depending on the extent of the disease, treatment may involve a Whipple procedure (pancreaticoduodenectomy), which removes the affected portion of the pancreas, duodenum, gallbladder and bile duct.

What Are the Causes and Risk Factors of Bile Duct Cancer?

The exact cause of cholangiocarcinoma is not always identifiable. However, several medical conditions and risk factors are associated with an increased likelihood of developing this cancer.

Important risk factors include:

1. Primary Sclerosing Cholangitis (PSC)

PSC is a chronic inflammatory condition that causes progressive scarring and narrowing of the bile ducts. It is an important risk factor for cholangiocarcinoma.

2. Chronic Bile Duct Inflammation

Long-standing inflammation and repeated injury to the bile ducts may increase the risk of abnormal cellular changes.

3. Choledochal Cysts

These are congenital abnormalities involving abnormal dilatation of the bile ducts. They are associated with an increased lifetime risk of biliary malignancy.

4. Liver Fluke Infection

Certain parasitic infections, particularly Clonorchis sinensis and Opisthorchis species, are associated with cholangiocarcinoma in endemic regions.

5. Chronic Liver Disease

Certain chronic liver conditions, including some forms of cirrhosis and chronic viral hepatitis, have been associated with increased risk, particularly of intrahepatic cholangiocarcinoma.

6. Increasing Age

Cholangiocarcinoma is more commonly diagnosed in older adults, although it can occur at younger ages as well.

It is important to understand that many patients diagnosed with bile duct cancer have no identifiable risk factors.

What Are the Early Warning Signs and Symptoms of Cholangiocarcinoma?

The symptoms of bile duct cancer depend largely on the location of the tumour and whether it is obstructing the flow of bile.

Some of the most important warning signs include:

1. Jaundice

Yellowing of the skin and eyes is one of the most important symptoms, particularly in perihilar and distal cholangiocarcinoma.

It occurs when bile cannot flow normally into the intestine, resulting in increased bilirubin levels in the blood.

2. Dark-Coloured Urine

Excess bilirubin in the blood may be excreted through the kidneys, making urine appear unusually dark or tea-coloured.

3. Pale-Coloured Stools

When bile cannot reach the intestine, stools may become pale, grey or clay-coloured.

4. Persistent Itching

Accumulation of bile-related substances in the bloodstream may cause significant itching, sometimes even before visible jaundice develops.

5. Unexplained Weight Loss

Unintentional weight loss, reduced appetite and general weakness may occur as the disease progresses.

6. Abdominal Pain

Some patients experience persistent discomfort or pain in the upper abdomen, particularly on the right side.

7. Fever and Chills

If a blocked bile duct becomes infected, a condition called acute cholangitis can develop. Fever, chills, abdominal pain and jaundice require urgent medical assessment.

Important: Persistent jaundice, particularly when associated with dark urine and pale stools, should never be ignored. Prompt evaluation by a gastroenterologist or HPB surgeon is essential.

How Is Bile Duct Cancer Diagnosed?

Accurate diagnosis and staging are essential before deciding on the appropriate treatment.

The diagnostic evaluation generally includes the following investigations.

1. Blood Investigations

Blood tests help assess liver function and identify abnormalities associated with biliary obstruction.

Common investigations include:

  • Liver Function Tests (LFT).

  • Complete Blood Count (CBC).

  • Tumour markers such as CA 19-9 and CEA.

CA 19-9 may be elevated in cholangiocarcinoma, but it is not specific to cancer. It can also increase in benign biliary obstruction and infection. Therefore, it should never be used alone to diagnose bile duct cancer.

2. Ultrasound Abdomen

Ultrasound is frequently the first investigation performed in patients presenting with jaundice.

It can identify:

  • Dilatation of the bile ducts.

  • Obstruction of the biliary system.

  • Liver abnormalities.

  • Gallstones and other possible causes of jaundice.

3. Contrast-Enhanced CT Scan

A multiphase contrast-enhanced CT scan helps determine the location and extent of the tumour.

It provides important information about:

  • Tumour size and extent.

  • Involvement of major blood vessels.

  • Liver involvement.

  • Regional lymph nodes.

  • Distant metastases.

4. MRI and MRCP

Magnetic Resonance Imaging (MRI) and Magnetic Resonance Cholangiopancreatography (MRCP) are particularly useful for evaluating the biliary anatomy.

They help identify the exact location and extent of bile duct involvement, especially in perihilar cholangiocarcinoma.

These investigations are important for surgical planning.

5. ERCP and Tissue Diagnosis

Endoscopic Retrograde Cholangiopancreatography (ERCP) may be performed to evaluate biliary obstruction, obtain brush cytology or tissue samples and insert a biliary stent when required.

In selected patients, Endoscopic Ultrasound (EUS)-guided tissue sampling may also be helpful.

The need and route for biopsy should be carefully planned by the treating multidisciplinary team, particularly when a tumour appears surgically resectable.

6. PET-CT Scan

PET-CT may be considered in selected cases to evaluate suspected lymph node involvement, distant metastases or disease recurrence. It is not routinely required for every patient.

What Are the Treatment Options for Bile Duct Cancer?

Treatment depends on the location of the cancer, tumour stage, involvement of blood vessels, presence of distant metastases and the patient's overall health.

Management should ideally be planned by a multidisciplinary team involving an HPB surgeon, medical oncologist, gastroenterologist, radiologist, pathologist and radiation oncologist.

1. Surgery – The Main Curative-Intent Treatment

Complete surgical removal of the tumour with clear margins (R0 resection) offers the best possibility of long-term disease control and potential cure in appropriately selected patients.

The type of operation depends on the location of the cancer.

Surgery for Intrahepatic Cholangiocarcinoma

The standard surgical approach generally involves removal of the affected part of the liver (hepatectomy), along with appropriate regional lymph node assessment.

Depending on tumour location and extent, this may involve:

  • Segmentectomy.

  • Sectionectomy.

  • Right or left hepatectomy.

  • Extended hepatectomy in selected patients.

The surgeon must carefully assess the future liver remnant to ensure that sufficient functioning liver will remain after surgery.

Surgery for Perihilar Cholangiocarcinoma

Perihilar cholangiocarcinoma often requires complex hepatobiliary surgery.

The operation may involve:

  • Removal of the extrahepatic bile duct.

  • Right or left hepatectomy.

  • Removal of the caudate lobe.

  • Regional lymph node dissection.

  • Reconstruction of the bile ducts using a Roux-en-Y hepaticojejunostomy.

These operations require detailed preoperative planning and considerable expertise in advanced hepatobiliary surgery.

Surgery for Distal Cholangiocarcinoma

Distal bile duct cancer is commonly treated with a Whipple procedure, also called pancreaticoduodenectomy.

This operation involves removal of:

  • The head of the pancreas.

  • The duodenum.

  • The gallbladder.

  • The distal common bile duct.

  • Regional lymph nodes.

Reconstruction is then performed to restore the continuity of the digestive system.

2. Laparoscopic and Robotic Surgery

Minimally invasive surgery has an evolving role in the management of selected patients with cholangiocarcinoma.

Depending on the tumour location, stage, surgical complexity and available expertise, laparoscopic or robotic approaches may be considered.

Potential advantages include:

  • Smaller surgical incisions.

  • Reduced postoperative pain.

  • Earlier mobilisation.

  • Potentially shorter hospital stay.

  • Faster recovery in appropriately selected patients.

However, minimally invasive surgery is not suitable for every patient. Achieving complete cancer clearance and maintaining patient safety must always take priority over the choice of surgical technique.

3. Biliary Drainage and Stenting

Patients with obstructive jaundice may require biliary drainage before definitive treatment.

This can be performed using:

  • ERCP-guided biliary stenting.

  • Percutaneous Transhepatic Biliary Drainage (PTBD).

  • Other selected endoscopic or image-guided drainage procedures.

Biliary drainage can relieve obstruction, reduce bilirubin levels and help manage cholangitis. In selected patients, it may also optimise liver function before major surgery.

However, biliary drainage is not a treatment that removes the underlying cancer.

4. Chemotherapy

Chemotherapy may be recommended after surgery or as the primary treatment in patients whose cancer cannot be completely removed surgically.

For advanced or metastatic biliary tract cancer, gemcitabine and cisplatin combined with an immune checkpoint inhibitor such as durvalumab or pembrolizumab are established first-line treatment options, depending on patient suitability and local availability.

After surgery, adjuvant chemotherapy may also be considered to reduce the risk of recurrence.

5. Targeted Therapy and Immunotherapy

Advances in cancer research have introduced new treatment options for selected patients with advanced cholangiocarcinoma.

Molecular testing of tumour tissue may identify specific genetic alterations that can be treated with targeted medicines.

Important molecular targets include:

  • FGFR2 gene fusions or rearrangements.

  • IDH1 mutations.

  • HER2 alterations.

  • BRAF V600E mutations.

  • NTRK gene fusions.

  • MSI-H or mismatch repair deficiency.

Targeted treatments may be beneficial in patients whose tumours carry the relevant molecular alterations.

Immunotherapy may also be used in appropriate clinical settings.

These developments highlight the importance of molecular profiling in patients with advanced bile duct cancer.

Can Bile Duct Cancer Be Cured?

Yes, bile duct cancer can potentially be cured in selected patients, particularly when the tumour is detected at an early stage and can be completely removed through surgery.

However, the possibility of cure depends on several factors:

  • Location of the tumour.

  • Stage of cancer at diagnosis.

  • Involvement of major blood vessels.

  • Presence or absence of lymph node and distant metastases.

  • Ability to achieve complete surgical removal.

  • Overall health and liver function of the patient.

Unfortunately, many patients are diagnosed when the cancer has already advanced beyond the possibility of complete surgical removal.

Even in such situations, chemotherapy, immunotherapy, targeted therapy, biliary drainage and other supportive treatments can help control the disease and improve quality of life.

Every patient requires an individualised treatment plan.